Lonny Reisman, MD, chief executive officer of HealthReveal, has a long history with The American Journal of Managed Care and its co-editors-in-chief A. Mark Fendrick, MD, and Michael E. Chernew, PhD, and said he is grateful for the work the journal has done over the years.
Lonny Reisman, MD, chief executive officer of HealthReveal, has a long history with The American Journal of Managed Care and its co-editors-in-chief A. Mark Fendrick, MD, and Michael E. Chernew, PhD, and said he is grateful for the work the journal has done over the years.
Transcript (slightly modified for readability)
Happy anniversary—20th—for AJMC. I've been following the journal for about as long as I remember. I probably could honeslty say about 20 years. Co-editors-in-chief Drs Mark Fendrick and Mike Chernew have been great friends and great supports of the work I've done over the years. And I've been particularly pleased not only to work with them but to access information about what is happenig in the world of managed care, in the world of value, reimbursement, and plan design from the sorts of publications that AJMC has made available not only to managed care companies, but to physicians and other types of executives. I'm thankful for your involvement.
I'm also grateful for the fact that the first article about my first company, a company called ActiveHealth, was actually published in 2005 in The American Journal of Managed Care. So I have a long history with the journal and am very grateful to the great work you've done.
Read the special guest commentary Dr Reisman wrote for AJMC's 20th anniversary.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More